BMRN ææ°ååæã®æ±ºç®å ±åæž
çºè¡šæ¥11/2/2026
EPSå®çžŸïŒUSDïŒ-0.63
売äžé«å®çžŸïŒUSDïŒ1.02B
BioMarin Pharmaceutical Incã®æ±ºç®æ¥ã»å ±åæž
ãã®ããŒãžã§ã¯ãææ°ã® BioMarin Pharmaceutical Inc ã®æ±ºç®å ±åæžã次å BioMarin Pharmaceutical Inc ã®æ±ºç®äºå®æ¥ãéå»ã®ããŒã¿ãBioMarin Pharmaceutical Inc ã®æ±ºç®é»è©±äŒè°ãã¥ãŒã¹ãªã©ã詳现㪠BioMarin Pharmaceutical Inc ã®æ±ºç®ããŒã¿ãæäŸããŠããŸãã
BMRN 次åååæã®æ±ºç®çºè¡šæ¥
çºè¡šæ¥--
EPSäºæ³ïŒUSDïŒ--
売äžé«äºæ³ïŒUSDïŒ--
BMRN FY2025 決ç®
EPS (å幎åææ¯)1.82-19.01%
売äžé« (å幎åææ¯)3.22B12.87%
BioMarin Pharmaceutical IncïŒBMRNïŒã®æ±ºç®å±¥æŽ
| å ¬éæ¥ | 察象æéçµäº | EPS/äºæž¬ | åç/äºæž¬ | EPSãµãã©ã€ãº % | 売äžé«ãµãã©ã€ãº % |
|---|---|---|---|---|---|
| 11/2/2026 | 09/2026 | -0.63/0.12 | 1.02B/1.03B | -634.13% | -0.15% |
| 8/6/2026 | 06/2026 | 0.23/0.69 | 989.71M/926.91M | -66.35% | 6.78% |
| 5/4/2026 | 03/2026 | 0.55/0.75 | 766.21M/756.00M | -26.97% | 1.35% |
| 2/23/2026 | 12/2025 | -0.24/0.62 | 874.57M/827.39M | -138.80% | 5.70% |
| 10/27/2025 | 09/2025 | -0.16/0.37 | 776.13M/780.63M | -143.05% | -0.58% |
| 8/4/2025 | 06/2025 | 1.25/0.83 | 825.41M/759.98M | 50.13% | 8.61% |
| 5/1/2025 | 03/2025 | 0.97/0.71 | 745.14M/740.72M | 37.26% | 0.60% |
| 2/19/2025 | 12/2024 | 0.66/0.53 | 747.31M/713.44M | 23.67% | 4.75% |
BioMarin Pharmaceutical Inc ææ°ã®æ±ºç®é»è©±äŒè°èšé²î
ãã€ãªããªã³ïŒBMRNïŒ2026幎第3ååæ決ç®èª¬æäŒïŒå£²äžé«10åãã«è¶ ãã¬ã€ãã³ã¹ãæŽæ°
ãã€ãªããªã³ã®2026幎第3ååæ決ç®èª¬æäŒã§ã¯ã10åãã«ãè¶
ãã売äžé«ã32%ã®æé·ãæŽæ°ããã2026幎ã®æ¥çžŸã¬ã€ãã³ã¹ãVOXZOGOã®å¢ããããã³ãã€ãã©ã€ã³ã®æ¡å€§ã«ã€ããŠèª¬æããªãããŸããã